Clinical Research Directory

Clinical Evaluation of the Adaptilens Accommodating IOL

The goal of this feasibility study is to learn more about the performance of the intraocular lens device, if the device is safe for use and what the best surgical techniques are for implanting the product in patients who require correction of aphakia following phacoemulsification extraction of a senile cataract. The main questions it aims to answer are: * Will the patient have any related complications? * Will a patient's vision improve after surgery? Researchers will compare the eye treated with the investigational product with the eye treated with another product to see if there are any differences in vision and safety. * Participants will be asked to attend all scheduled visits for the study, approximately 11 visits in total over 3 years. * During these visits the participants will be asked about their medical history, have testing and measurements taken, and one visit that is the scheduled surgery. The participants will be asked to use eye drops that have been prescribed by the doctor performing the surgery.

Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

This is an observational, follow up study of subjects previously enrolled in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study". The primary objective of this study is to collect long-term safety and effectiveness data on RxSight LAL and Control IOL in subjects previously implanted in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study".